MCM
KALA icon

MAI Capital Management’s KALA BIO KALA Stock Holding History

MAI Capital Management’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-6
Closed -$52 – 3457
2026
Q1 		$52 Hold
6
– – ﹤0.01% 4862
2025
Q4 		$167 Hold
6
– – ﹤0.01% 4089
2025
Q3 		$459 Hold
6
– – ﹤0.01% 3632
2025
Q2 		$1.43K Hold
6
– – ﹤0.01% 3521
2025
Q1 		$1.72K Hold
6
– – ﹤0.01% 3006
2024
Q4 		$2.08K Buy
+6
New +$1.89K ﹤0.01% 3027
2022
Q2 		– Sell
-29
Closed -$100K – 940
2022
Q1 		$100K Buy
+29
New +$76K ﹤0.01% 857

Other funds holding KALA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

MAI Capital Management's KALA Position: Q2 2026 in Review

MAI Capital Management sold out of KALA BIO (KALA) in Q2 2026, closing a stake of 6 shares — an estimated $52 sold.

MAI Capital Management first reported a position in KALA in Q1 2022 and held it in 7 quarters. The position peaked at $100K in Q1 2022. 14 funds tracked by Wall St. Rank hold KALA as of Q2 2026.

  • MAI Capital Management reported no remaining KALA BIO position as of Q2 2026 after selling out during the quarter.
  • MAI Capital Management sold 6 KALA BIO shares in Q2 2026, an estimated $52.
  • MAI Capital Management first reported a position in KALA BIO in Q1 2022 and held it in 7 quarters.
  • MAI Capital Management's KALA BIO position peaked at $100K in Q1 2022.
  • 14 funds tracked by Wall St. Rank held KALA BIO as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.